Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
87.60M | 55.76M | 57.66M | 66.81M | 42.76M | Gross Profit |
9.03M | 2.12M | 9.90M | 11.66M | 5.47M | EBIT |
-13.34M | -27.03M | -21.04M | -13.01M | -19.99M | EBITDA |
802.00K | -10.76M | -5.63M | -7.18M | -15.98M | Net Income Common Stockholders |
-9.79M | -24.56M | -21.07M | -19.43M | -28.11M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
45.69M | 5.92M | 6.19M | 16.73M | 10.70M | Total Assets |
90.71M | 84.40M | 102.21M | 119.89M | 114.27M | Total Debt |
1.90M | 14.45M | 15.36M | 13.57M | 20.39M | Net Debt |
-43.79M | 8.54M | 9.17M | -3.16M | 9.70M | Total Liabilities |
17.21M | 36.42M | 29.80M | 26.41M | 31.28M | Stockholders Equity |
73.50M | 47.98M | 72.41M | 93.48M | 82.99M |
Cash Flow | Free Cash Flow | |||
-18.01M | -1.29M | -4.24M | -16.96M | -15.07M | Operating Cash Flow |
-17.60M | -1.28M | -3.58M | 1.14M | 2.31M | Investing Cash Flow |
32.83M | 41.00K | -561.00K | -17.10M | -17.43M | Financing Cash Flow |
24.55M | 963.00K | -6.40M | 21.97M | -1.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $6.93B | 11.84 | 2.89% | 3.91% | 2.59% | -21.68% | |
53 Neutral | HK$1.30B | ― | -30.10% | ― | 130.71% | 51.92% | |
51 Neutral | HK$65.02M | ― | -15.55% | ― | 47.54% | 91.35% | |
44 Neutral | HK$37.99M | ― | -12.75% | ― | 86.07% | 84.96% | |
36 Underperform | HK$57.16M | ― | -114.02% | ― | ― | -51.39% |